title: [Economic aspects of evidence-based metaphylaxis].
abstract: The calculation model which we developed for the cost of stone therapy and metaphylaxis in Germany some years ago with a social health insurance company is based on estimates of stone incidence, types and recurrence rates, actual costs for stone removal, and metaphylaxis (based on data from a district of the social health care system). There are 200,000 stone recurrences per year in Germany. Costs for treatment of these stones amount to $687,000,000. Stone metaphylaxis reduces the recurrence rate by some 40%. The annual cost for stone removal could be lowered by $275,300,000. Metabolic evaluation/metaphylaxis amount to $70,100,000 per year, resulting in a net saving of $205,200,000. In 1997, there were 96 days off work per stone patient resulting in 5,800,000 days off work in Germany per year. Metaphylaxis is not only medically effective in stone formers but also can lower health care cost significantly. Although health care conditions may vary from country to country, in principle this calculation model is applicable also to other countries.
authors.affiliation: Klinik für Urologie und Kinderurologie, Klinikum, Coburg. walter.strohmaier@klinikum-coburg.de
authors.forename: W L
authors.initials: WL
authors.lastname: Strohmaier
mesh_terms: D003362:Cost-Benefit Analysis; D019317:Evidence-Based Medicine / Q000191:economics*; D005858:Germany; D006801:Humans; D007669:Kidney Calculi / Q000737:chemistry / Q000191:economics / Q000209:etiology / Q000517:prevention & control; D008096:Lithotripsy / Q000191:economics; D009313:National Health Programs / Q000191:economics; D012307:Risk Factors; D014514:Ureteral Calculi / Q000737:chemistry / Q000191:economics / Q000209:etiology / Q000517:prevention & control; D014545:Urinary Calculi / Q000737:chemistry / Q000191:economics* / Q000209:etiology / Q000517:prevention & control